Genscript Biotech ( (HK:1548) ) has issued an announcement.
Genscript Biotech Corporation has announced the composition of its board of directors and the roles they will undertake. The board includes a mix of executive, non-executive, and independent non-executive directors, with various members serving on five established committees. This announcement highlights the company’s commitment to strong governance and strategic oversight, which is crucial for maintaining its competitive position in the biotechnology sector.
More about Genscript Biotech
Genscript Biotech Corporation, incorporated in the Cayman Islands, operates in the biotechnology industry. The company focuses on providing a range of services and products related to gene synthesis, peptide synthesis, protein production, and antibody development, catering to the needs of researchers and pharmaceutical companies worldwide.
YTD Price Performance: 13.39%
Average Trading Volume: 3,834
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.72B
See more insights into 1548 stock on TipRanks’ Stock Analysis page.